InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,618.26
(
-0.29%
)
US TECH 100
18,951.20
(
0.06%
)
Dow Jones
41,503.10
(
-0.25%
)
Brent Oil
72.38
(
-1.28%
)
Bitcoin
60,575.53
(
0.46%
)
Post# of 11473
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

guay

Send PM Follow Ignore
Followers 31
Posts 3389
Boards Moderated 0
Alias Born 08/04/2009

guay

Re: guay post# 5596

Wednesday, 02/21/2018 7:30:07 AM

Wednesday, February 21, 2018 7:30:07 AM

Post# of 11473
Emerald Health (EMHTF) is very well positioned. Although we currently think that the mass of private consumers will bring in the big money – IMO on the long run it will be earned in the scientifical, medical field. Serving the mass demand is a purely economic-organizational diligence task. The medical field is the scientific part, it has something to do with knowledge and that is THE unique feature or unique selling proposition of a company. Patents make it easier to stand out from the competition, than through a perpetual price war.
https://finance.yahoo.com/news/emerald-health-pharmaceuticals-present-sachs-080000443.html

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up